Erste Group Downgrades CA Immo to Hold
Erste Group has downgraded its rating for CA Immo to 'Hold' and reduced its price target to 23.6 Euro.
Stocks · News reference
BTIG Maintains Buy Rating and Raises Price Target for Caris Life Sciences
BTIG analyst Mark Massaro has reaffirmed a "Buy" rating on Caris Life Sciences and increased the price target from $33 to $38.
Reference Details
Connected Markets
Poisar stores the source's headline, summary and market tags for reference. Reporting and full article text remain with the original publisher.
- Source
- fiscal.ai
- Observed
- Checked
- Cadence
- Captured once, then retained as an archive reference
- Status
- fresh
Keep reading
Related Headlines
Canaccord Genuity Maintains Hold on Caris Life Sciences, Raises Price Target to $30
Truist Financial, Regions Financial And Other Big Stocks Moving Lower In Friday’s Pre-Market Session
U.S. stock futures mixed; Truist slips after mixed results, while Telkom Indonesia, Loma Negra, Omeros and others fall premarket.